The 93rd CMEF has concluded. At this exhibition, Shurui® sent an even clearer and more definitive signal: minimally invasive surgery is entering a new phase of upgrading to single-port techniques, and Chinese surgical robotics is entering a new phase of competition centered on direction.

The global debut of Shurui®'s next-generation full-domain single-port surgical robot, the SR-ENS-660, took place at CMEF. This launch addresses not merely how to upgrade a product generation, but rather the question of where surgical technology is headed in the next phase. Shurui®'s judgment is unambiguous: the core mission of the next phase of surgical robot development is to drive surgery from multi-port toward single-port, from traditional minimally invasive surgery toward a higher level of ultra-minimally invasive surgery. This is the fundamental logic behind Shurui®'s continuous efforts to upgrade its full-domain single-port platform.

Globally, minimally invasive surgery is entering a new phase of advancement. Single-port surgery is accelerating its move toward clinical mainstream adoption. At the same time, traditional single-port technology still faces realistic challenges in clinical adaptability, scenario integration, and large-scale dissemination, and hospitals have consistently lacked a smooth upgrade path from multi-port to single-port.

This represents a critical inflection point for the industry. Over the past many years, China's surgical robotics industry has accomplished a major leap from nothing to something, from following to catching up, and from partial breakthroughs to comprehensive platform refinement. Today, the core question for the industry is no longer simply "whether we have it" or "whether it looks similar," but rather where to go in the next phase and who will chart the new path.

This year's CMEF unfolded precisely against this backdrop. As a major global platform for medical technology exchange, CMEF has become an important window for international clients, experts, and partners to observe the innovation capabilities and technological direction of China's high-end medical equipment. The global debut of Shurui®'s next-generation full-domain single-port surgical robot, the SR-ENS-660, propels single-port technology into a new phase of greater intelligence, enhanced versatility, and higher efficiency, while also providing a new Chinese pathway for the global upgrade of minimally invasive surgery.

The value of Shurui®'s single-port robot is no longer merely about achieving coverage across all surgical disciplines and procedure types, but about continuously advancing existing advantages into higher-quality surgical execution across multiple key dimensions, including complex surgeries, surgical efficiency, operational capability, and the value of ultra-minimally invasive surgery.

At the exhibition site, Shurui® presented concentrated clinical achievements covering over 7 core disciplines, more than 200 procedure types, and over 4,000 cases of high-quality clinical outcomes. This led many attending hospital administrators and clinical experts to reassess the realistic boundaries of single-port technology. In the past, many people's understanding of minimally invasive upgrades remained confined to existing pathways, and there was a widespread belief that single-port technology faced insurmountable barriers. However, Shurui®'s snake-arm single-port robot, with its independently developed original technological pathway and solid clinical outcomes, has clearly demonstrated that single-port technology has not only crossed key thresholds but also exhibits more complete platform value and higher-level clinical capabilities in certain disciplines and complex scenarios where traditional multi-port systems are not fully adapted.

More importantly, what Shurui® presented this time is not merely a concentrated release of single-port achievements, but a clear answer to the future direction of single-port technology. The replacement of multi-port by single-port is steadily advancing toward clinical reality. Shurui® is also becoming the most practically significant benchmark for the industry to observe the future trajectory of single-port technology.

Driven by continuous upgrades to its full-domain single-port platform, Shurui®'s next-generation full-domain single-port surgical robot, the SR-ENS-660, has achieved systematic breakthroughs across four key dimensions. What is presented here is not a simple addition of several functional points, but an overall leap forward in intraoperative experience, capability to complete complex scenarios, system evolution capability, and clinical implementation capability for the full-domain single-port platform.

Shurui® has further upgraded the dual-mode glasses-free 3D visual imaging system, truly integrating open glasses-free 3D and immersive visual modes within the same platform. Depending on the procedure, scenario, and personal preference, surgeons can freely choose the more suitable visual approach, further enhancing intraoperative comfort and adaptability for identification, judgment, and observation, while also granting greater freedom for operational expression integrating virtual and real elements.

Addressing the higher demands of single-port surgery for efficient tissue management, stable suturing and reconstruction, and deep, flexible observation, Shurui® continues to refine its advanced single-port instrument system.

S-Energy Combined Coagulation-Cutting Device: As the world's only surgical robot-compatible combined monopolar/bipolar tool, it integrates monopolar and bipolar capabilities into a single instrument, allowing flexible switching based on intraoperative needs, thereby further improving tissue processing efficiency and energy application efficiency during surgery.

Enhanced Needle Holders and Tissue Graspers: Designed for high-workload scenarios such as large fibroids, gastric cancer, and complex reconstructions, these further enhance instrument load capacity, stable control capability, and complex suturing and reconstruction capability.

High-Durability Articulating Endoscope: Overcoming the application challenges of single-port endoscopes in complex scenarios, it achieves a wide 90-degree range of articulation while maintaining a long service life, further enhancing visual field adjustability and operational freedom in deep, narrow, and angular complex spaces.

These three types of instruments work synergistically, advancing single-port surgery from "routine application" toward "higher quality standards."

TheDeveloper Intelligent Interactive System is an intelligent platform open to both clinical and R&D communities, and an important vehicle allowing surgeons to actively participate in feature development and platform iteration.

Focused on real surgical workflows, Shurui® has achieved upgrades across multiple levels, including operating experience, workflow coordination, intelligent optimization, and platform modes. Whether it is the intuitive master controller with force self-adaptation, the surgeon's field-of-view self-adjustment, automatic console adjustment, remote-controlled mobility, ultra-short startup time, or one-button system undeploy, each enhancement improves the platform's understanding of surgeon habits and clinical processes. Notably, the ultra-short startup time reduces startup time by approximately half, further improving surgical transition efficiency. The single/multi-port hybrid surgical system supports switching between single-port, multi-port, and hybrid-port modes, further enhancing the platform's capability to handle different procedure types and scenarios. What the Developer Intelligent Interactive System drives is a shift of surgical robots from "device responsiveness" toward "system understanding," truly realizing the upgrade from surgeons adapting to the machine to the machine understanding the surgeon.

Shurui® has further refined its single/multi-port hybrid surgical system, maintaining single-port as the core while enhancing capability in complex scenarios with hybrid-port and creating platform expansion space with multi-port capability. This platform configuration allows hospitals and departments to rely on the same platform for a gradual introduction, progressing from routine procedures to complex case management and then to deepening single-port techniques, further enhancing the capability of single-port technology to be adopted and implemented in real-world clinical scenarios.

The coordinated advancement across these four dimensions has propelled Shurui®'s full-domain single-port robot into a new phase of greater intelligence, enhanced versatility, and higher efficiency, while also providing more solid platform support for the continued pursuit of higher-quality applications in single-port surgery.

Today's CMEF has become an important window for global customers, international experts, and overseas partners to observe the innovation capabilities and technological direction of China's high-end medical equipment.

At this CMEF, Shurui® globally debuted the SR-ENS-660 and engaged in in-depth discussions with customers, experts, and partners from numerous countries and regions across Europe, the Middle East, Southeast Asia, and Latin America. The Shurui® booth was also a consistent focal point visited and revisited by overseas customers. This indicates that the international market's attention toward Chinese surgical robots is shifting from manufacturing capability, cost advantages, and substitution potential toward a reassessment of technological pathways, platform value, and future positioning.

What Shurui® presents is precisely a globally significant, original Chinese pathway: based on snake-arm technology, centered on a full-domain single-port platform, and supported by clinical mainstreaming capability, driving minimally invasive surgery to continue evolving toward smaller trauma, higher integration, and greater platform efficiency. Numerous overseas experts, after hands-on experience at the venue, paid close attention to the flexibility, ease of use, and clinical adaptability of Shurui®'s single-port platform. An even more direct piece of feedback was that throughout the operation, users hardly felt the constrained sensation common with traditional single-port approaches; the operation felt natural and smooth, the overall logic highly aligned with surgeon habits, and the clinical value clearly exceeded expectations. The growing interest from international customers in Shurui® reflects not merely interest in a single product, but a reassessment of the value of China's original technological pathway and the next-generation minimally invasive surgical platform.

From multi-port to single-port, each iteration of minimally invasive surgery drives the field toward smaller trauma, higher precision, and faster recovery. Today, Shurui®, with its full-domain single-port platform as the core and further integration of the single/multi-port hybrid surgical system, is advancing single-port from a frontier exploration to a realistic pathway with greater clinical implementation capability and platform expansion space.

Shurui®'s next-generation full-domain single-port surgical robot, leveraging the independently developed original snake-arm technology, continues to expand the boundaries of single-port application in complex surgeries and provides a clearer, original Chinese pathway for the development of ultra-minimally invasive surgery. In the future, Shurui® will continue to deeply cultivate single-port technology innovation, driving the upgrade of complex surgeries to single-port approaches.

While the industry is still debating whether single-port will become mainstream, Shurui® is already turning the platform, clinical capabilities, and pathways needed for the mainstreaming of single-port into reality.